honokiol has been researched along with Pulmonary Embolism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Ge, X; Han, J; Jia, D; Xu, C; Yuan, J | 1 |
1 other study(ies) available for honokiol and Pulmonary Embolism
| Article | Year |
|---|---|
Sirtuin3 confers protection against acute pulmonary embolism through anti-inflammation, and anti-oxidative stress, and anti-apoptosis properties: participation of the AMP-activated protein kinase/mammalian target of rapamycin pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Hominidae; Mammals; Oxidative Stress; Pulmonary Embolism; Rats; Signal Transduction; Sirolimus; Sirtuin 3; TOR Serine-Threonine Kinases | 2023 |